medigraphic.com

2023, Number 2

<< Back Next >>

Folia 2023; 17 (2)

Prevention of disabilities due to leprosy in the training of professionals at the first level of care

Alemán MT, Hernández ADM, Concepción PJA

Language: Spanish
References: 12
Page:
PDF size: 410.22 Kb.


ABSTRACT

Introduction: Leprosy is a stigmatizing disease that causes deformities and disabilities, which imply a social impact on those who suffer from it, the family and the community. Early diagnosis, proper management of leprous reactions, and timely treatment are vital for their control, because it cures the patient, interrupts transmission, and prevents disabilities.
Objective: To establish leprosy prevention actions in the training of professionals at the first level of care.
Methods: A literature review was conducted from January to March 2023. Google Scholar, PubMed, and SciELO were used as search engines. The keywords leprosy, diagnostic ability, prevention and rehabilitation were used. The reviewed articles were usually less than 10 years old and referred to the topic of study through the title. Of the 52 articles retrieved, 23 were selected for research.
Conclusions: Disability due to leprosy is avoidable; so medical, social, political and scientific efforts must be joined to project them towards prevention, early diagnosis, timely treatment and rehabilitation of patients affected by this disease.


REFERENCES

  1. Consulich L, Meik S, Vicente AM, Abeldańo A. Pápulas foliculares pruriginosas. Rev.Dermatol. Arg. 2012 [acceso 20/09/2022];18(5):405-08. Disponible en:https://www.dermatolarg.org.ar

  2. González Escudero M, Chamizo Cabreras M, Betancourt Pérez A. Enfermedad de Fox-Fordyce, presentación de una paciente. Acta Médica del Centro. 2014 [acceso20/08/2022]:8(3). Disponible en: https://www.revactamedicacenro.sld.cu

  3. Contreras-Gala KL. Prurito vulvar y enfermedad de Fox-Fordyce, un reporte de caso.Rev. Fac. Med. Hum. 2020 [acceso 28/08/2022];20(2):319-21. Disponible en:http://dx.doi.org/10.25176/rfmh.v20i2.2516

  4. Scroggins L, Kelly E, Kelly B. Fox-Fordyce Disease in Daughter and Father.Dermatology. 2009;218:176-7. DOI: http://doi.org/10.1159/000182271

  5. Mataix J, Silvestre JF, Niveiro M, Lucas A. Perifollicular xanthomatosis as a keyhistological finding in Fox-Fordyce disease. Actas Dermosifiliogr. 2008 [acceso20/08/2022];99:145-8. Disponible en: https://www.actasdermo.org

  6. Pock L, Svrcková M, Machácková R, Hercogová J. Pimecrolimus is effective in Fox-Fordyce disease. Int. J. Dermatol. 2006;45(9):1134-5. DOI:http://doi.org/10.1111/j.1365-4632.2006.02878.x

  7. Böer A. Patterns histopathologic of Fox-Fordyce disease. Am. J. Dermatopathol.2004;26(6):482-92. DOI: http://doi.org/10.1097/00000372-200412000-00008

  8. Macarenco RS, Garces S. Dilatation of apocrine glands. A forgotten but helpfulhistopathological clue to the diagnosis of axillary Fox-Fordyce disease. Am. J.Dermatopathol. 2009;31(4):393-7. DOI: http://doi.org/10.1097/DAD.0b013e318197b7fd

  9. Bormate AB, Leboit PE, McCalmont TH. Perifollicular xanthomatosis as the hallmarkof axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases.Arch. Dermatol. 2008;144(8):1020-4. DOI: http://doi.org/10.1001/archinternmed.2008.3

  10. Kao PH, Hsu CK, Lee JY. Clinicopathological study of Fox-Fordyce disease. J.Dermatol. 2009;36(9):485-90. DOI: http://doi.org/10.1111/j.1346-8138.2009.00689.x

  11. Bolognia J, Schaffer J, Cerroni L. editores. Dermatología. 4 ed. New York: Elsevier;2019. p. 288-323.

  12. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 6 ed. México, DF: McGraw Hill; 2019.




2020     |     www.medigraphic.com